Moneycontrol PRO
Loans
HomeNewsAsterdmhealth

At Moneycontrol, the Results page helps you effectively track corporate announcements and results for various listed companies across both India and abroad. With our Results page, you can keep abreast with an updated, comprehensive view of all the profit/loss statements, company spendings, AGM outcomes, and quarterly and annual results from all these listed companies. Additionally, Moneycontrol also regularly tracks international MNCs listed on NASDAQ and Asian bourses, including popular companies like Apple, Google, Alibaba. Apart from finding solid copies of company results, stock movements consequent to these company results, expectations, and analytical post results copies, you will also find copies and articles detailing the earnings, impact, and all major announcements made to media/exchanges by these companies, so that you do not miss anything. We also provide you with concrete data points to help you spot profitable trades, stock build-ups, and bulk deals. At Moneycontrol, we also cover analysts/investors meetings; scrutinise results and data and BSE/NSE reports or news. The copies are not just full of information and data, but are also adequately supplemented with expert views, investor opinions, extensive interviews, videos, and a huge variety of explainers, analyses, and informative slideshows to help you gauge the market and make investment decisions in the best possible manner. More

Jump to
  • Aster DM Q1 PAT seen up 276.5% YoY to Rs. 167.4 cr: ICICI Direct

    Net Sales are expected to increase by 10.7 percent Y-o-Y (down 3.7 percent Q-o-Q) to Rs. 2,625.9 crore, according to ICICI Direct.

  • Aster DM Healthcare Q1 PAT seen up 112.3% YoY to Rs 94.4 cr: Prabhudas Lilladher

    Aster DM Healthcare Q1 PAT seen up 112.3% YoY to Rs 94.4 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 5.7 percent Y-o-Y (down 8.1 percent Q-o-Q) to Rs 2,506.2 crore, according to Prabhudas Lilladher.

  • Aster DM Q4 PAT seen up 81.4% YoY to Rs. 191.2 cr: ICICI Direct

    Aster DM Q4 PAT seen up 81.4% YoY to Rs. 191.2 cr: ICICI Direct

    Net Sales are expected to increase by 11.7 percent Y-o-Y (up 0.8 percent Q-o-Q) to Rs. 2,671.4 crore, according to ICICI Direct.

  • Aster DM Q3 PAT seen up 68.5% YoY to Rs. 155.8 cr: ICICI Direct

    Aster DM Q3 PAT seen up 68.5% YoY to Rs. 155.8 cr: ICICI Direct

    Net Sales are expected to increase by 12 percent Y-o-Y (down 0.4 percent Q-o-Q) to Rs. 2,494 crore, according to ICICI Direct.

  • Aster DM Healthcare Q2 PAT may dip 56.6% YoY to Rs. 4.8 cr: Kotak

    Aster DM Healthcare Q2 PAT may dip 56.6% YoY to Rs. 4.8 cr: Kotak

    Net Sales are expected to increase by 12.4 percent Y-o-Y (up 1.7 percent Q-o-Q) to Rs. 2,064 crore, according to Kotak.

  • Aster DM Healthcare Q1 PAT seen up 47.3% YoY to Rs. 18.3 cr: Kotak

    Aster DM Healthcare Q1 PAT seen up 47.3% YoY to Rs. 18.3 cr: Kotak

    Net Sales are expected to increase by 15.2 percent Y-o-Y (down 7.1 percent Q-o-Q) to Rs. 2,045.2 crore, according to Kotak.

  • Aster DM Healthcare Q4 PAT may dip 6.7% YoY to Rs. 177.4 cr: Kotak

    Aster DM Healthcare Q4 PAT may dip 6.7% YoY to Rs. 177.4 cr: Kotak

    Net Sales are expected to increase by 20.9 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs. 2,156.9 crore, according to Kotak.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347